Prediction of virus-host interactions and identification of hot spot residues of DENV-2 and SH3 domain interactions.
DENV-2
Dengue
Peptide-based vaccines
Proline
SH3 domain
Journal
Archives of microbiology
ISSN: 1432-072X
Titre abrégé: Arch Microbiol
Pays: Germany
ID NLM: 0410427
Informations de publication
Date de publication:
14 Mar 2024
14 Mar 2024
Historique:
received:
16
12
2023
accepted:
08
02
2024
revised:
08
02
2024
medline:
18
3
2024
pubmed:
14
3
2024
entrez:
14
3
2024
Statut:
epublish
Résumé
Dengue virus, particularly serotype 2 (DENV-2), poses a significant global health threat, and understanding the molecular basis of its interactions with host cell proteins is imperative for developing targeted therapeutic strategies. This study elucidated the interactions between proline-enriched motifs and Src homology 3 (SH3) domain. The SH3 domain is pivotal in mediating protein-protein interactions, particularly by recognizing and binding to proline-rich regions in partner proteins. Through a computational pipeline, we analyzed the interactions and binding modes of proline-enriched motifs with SH3 domains, identified new potential DENV-2 interactions with the SH3 domain, and revealed potential hot spot residues, underscoring their significance in the viral life cycle. This comprehensive analysis provides crucial insights into the molecular basis of DENV-2 infection, highlighting conserved and serotype-specific interactions. The identified hot spot residues offer potential targets for therapeutic intervention, laying the foundation for developing antiviral strategies against Dengue virus infection. These findings contribute to the broader understanding of viral-host interactions and provide a roadmap for future research on Dengue virus pathogenesis and treatment.
Identifiants
pubmed: 38483579
doi: 10.1007/s00203-024-03892-x
pii: 10.1007/s00203-024-03892-x
pmc: PMC10940428
doi:
Substances chimiques
Proline
9DLQ4CIU6V
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
162Informations de copyright
© 2024. The Author(s).
Références
Methods Mol Biol. 2015;1268:89-141
pubmed: 25555723
J Comput Chem. 2004 Oct;25(13):1605-12
pubmed: 15264254
Curr Microbiol. 2021 Jan;78(1):17-32
pubmed: 33231723
Sci STKE. 2004 Feb 03;2004(219):pl2
pubmed: 14872095
J Mol Biol. 2005 Feb 4;345(5):1281-94
pubmed: 15644221
Nucleic Acids Res. 2004 Jan 1;32(Database issue):D115-9
pubmed: 14681372
Cell Death Discov. 2020 Oct 2;6(1):96
pubmed: 33024578
Front Biosci. 2008 May 01;13:4938-52
pubmed: 18508559
Front Public Health. 2021 Oct 05;9:715759
pubmed: 34676194
J Mol Biol. 2011 Sep 23;412(3):319-24
pubmed: 21802429
Traffic. 2011 Oct;12(10):1282-90
pubmed: 21518163
Elife. 2015 Jun 30;4:e08347
pubmed: 26126267
Arch Microbiol. 2023 Dec 20;206(1):30
pubmed: 38117335
Nucleic Acids Res. 2005 Jul 1;33(Web Server issue):W382-8
pubmed: 15980494
Nature. 2013 Apr 25;496(7446):504-7
pubmed: 23563266
Hum Vaccin. 2011 Jun;7(6):674-84
pubmed: 21508679
Bioinformatics. 2019 Oct 15;35(20):4170-4172
pubmed: 30865258
Structure. 2022 Jun 2;30(6):828-839.e6
pubmed: 35390274
Bioinformatics. 2013 May 15;29(10):1357-8
pubmed: 23515528
Curr Med Chem. 2006;13(22):2607-25
pubmed: 17017914
J Mol Biol. 2007 Sep 21;372(3):774-97
pubmed: 17681537
BioDrugs. 2022 May;36(3):325-336
pubmed: 35608749
EXCLI J. 2023 Oct 26;22:1113-1128
pubmed: 38054205
PLoS Pathog. 2011 Nov;7(11):e1002383
pubmed: 22114558
Structure. 2010 Feb 10;18(2):188-99
pubmed: 20159464
PLoS One. 2008 Jul 02;3(7):e2524
pubmed: 18596940
Front Cell Infect Microbiol. 2017 Jul 12;7:317
pubmed: 28748176
PLoS Pathog. 2021 Nov 15;17(11):e1009728
pubmed: 34780577
Nucleic Acids Res. 2014 Jan;42(Database issue):D374-9
pubmed: 24081580
Asian Pac J Trop Biomed. 2013 Mar;3(3):232-6
pubmed: 23620845
BMC Bioinformatics. 2008 Oct 21;9:447
pubmed: 18939967
BMC Struct Biol. 2010 Jun 16;10:17
pubmed: 20550721
J Virol. 2014 Dec;88(23):13759-68
pubmed: 25231318
Genet Vaccines Ther. 2012 Aug 28;10(1):6
pubmed: 22929369
Curr Treat Options Infect Dis. 2023;15(2):27-52
pubmed: 37124673
EMBO J. 1995 Feb 1;14(3):484-91
pubmed: 7859737
PeerJ. 2018 Oct 31;6:e5858
pubmed: 30402352
Science. 1995 Jan 20;267(5196):383-6
pubmed: 7529940
J Mol Biol. 1998 Jul 3;280(1):1-9
pubmed: 9653027
Virol J. 2008 Feb 11;5:24
pubmed: 18267011
J Biol Chem. 2009 Feb 20;284(8):4921-35
pubmed: 19091746
Curr Opin Struct Biol. 2002 Feb;12(1):14-20
pubmed: 11839484
Curr Pharm Des. 2012;18(9):1255-65
pubmed: 22316154
Thromb Haemost. 2009 Dec;102(6):1042-9
pubmed: 19967133